Corcept Therapeutics Incorporated Common Stock (NASDAQ: CORT) last traded at $122.25, up 0.99% on the session. The quote above updates while this page is open; the figures below are drawn from Corcept Therapeutics Incorporated Common Stock’s own filings and are restated only when a new one is published.
Corcept Therapeutics Incorporated Common Stock trades on NASDAQ under the ticker CORT. Its market capitalisation is $13.22 billion.
Valuation measures for Corcept Therapeutics Incorporated Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $13.22B |
|---|---|
| Enterprise value | $13.29B |
| P/E ratio | 291.07 |
| Price / sales | 15.91 |
| Price / book | 18.72 |
| Beta | 1.84 |
Trailing-twelve-month figures tagged in Corcept Therapeutics Incorporated Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $830.81M |
|---|---|
| Net income (TTM) | $55.18M |
| EPS (TTM) | $0.420 |
| Operating margin | 0.77% |
| Return on equity | 7.82% |
| Cash | $111.04M |
Range and volume for CORT over the past 52 weeks.
| 52-week high | $123.44 |
|---|---|
| 52-week low | $28.66 |
| Volume | 639.4K |
| Average volume | 1.10M |
| Previous close | $121.05 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.